Abstract:Summary In this Review, we examine the concurrent outbreaks of mpox in Africa, focusing on clade 1a, the newly emerged clade 1b, and clade 2b lineage A, and how they differ from the 2022 global outbreak caused by clade 2b lineage B.1. Historically, clades 1a and 2a have caused sporadic, small outbreaks in central and west Africa, respectively, primarily through zoonotic transmission. Clade 2b first caused an outbreak in Nigeria in 2017, and later spread globally via sexual contact in 2022. In August, 2024, WHO declared a global health emergency due to the newly identified clade 1b outbreak in eastern Democratic Republic of the Congo. This outbreak has now expanded to several other countries and is spreading through direct and sexual contact in urban centres and refugee camps. Clades, route of exposure, infectious dose, and host immune response are the main factors influencing clinical presentation of mpox. For clades 1a and 2a, zoonotic transmission plays an important role, whereas for clades 1b and 2b, the spread occurs through sustained human-to-human transmission without zoonotic exposure. For both clades 1a and 2a, lesions have a generalised centrifugal distribution, whereas for clade 2b they are mainly localised to the anogenital area. For clade 1b, data are still emerging, but current cases show a mix of localised lesions and centrifugal distribution. The severity of the disease is higher for clade 1a (case fatality rate up to 12%) compared with other clades (case fatality rates 0–3·6%). Diagnostic challenges include false negative results for clade 1b with existing PCR assays and poor testing access in remote areas. Tecovirimat, the primary antiviral during the 2022 outbreak, has shown reduced effectiveness against clade 1a in preliminary study results, whereas its efficacy against other clades is still under investigation. The modified vaccinia Ankara–Bavarian Nordic vaccine has been shown to be up to 90% effective against clade 2b after two doses and is safe for children, although its effectiveness drops to 20% when used as post-exposure prophylaxis. Given the evolving nature of the monkeypox virus, ongoing research and strong public health responses are key to managing potential future outbreaks.

Editorial: Reasons for Increasing Global Concerns for the Spread of Mpox

The 2024 Public Health Emergency of International Concern: A Global Failure to Control Mpox

Insights into the Monkeypox virus: making of another pandemic within the pandemic?

Monkeypox: A current emergency global health threat

Mpox continues to spread in Africa and threatens global health security

Monkeypox Outbreak 2022, from a Rare Disease to Global Health Emergence: Implications for Travellers

Public Health Emergency of International Concern declared by the World Health Organization for Monkeypox

Monkeypox Mysteries of the New Outbreak in Non-Endemic Areas

Mpox global health emergency: Insights into the virus, immune responses, and advancements in vaccines PART I: Insights into the virus and immune responses

Mpox needs a locally tailored global response

Mpox and Lessons Learned in the Light of the Recent Outbreak: A Narrative Review

Prediction of potential public health risk of the recent multicountry monkeypox outbreak: An update after the end declaration of global public health emergency

Review of the prevalence, diagnostics, and containment measures of the current mpox outbreak

Unusual Global Outbreak of Monkeypox: What Should We Do?

An overview of the progress made in research into the Mpox virus

The Mpox outbreak is a public health emergency of international concern: Implications for mental health and global preparedness

Making Sense of Monkeypox: A Comparison of Other Poxviruses to the Monkeypox

Insights into the challenging multi-country outbreak of Mpox: a comprehensive review

A critical review of mpox outbreaks, risk factors, and prevention efforts in Africa: lessons learned and evolving practices

Concurrent outbreaks of mpox in Africa—an update

Monkeypox Virus and Other Emerging Outbreaks: An Overview and Future Perspective